By a News Reporter-Staff News Editor at Biotech Week -- Fresh data on Oncology are presented in a new report. According to news reporting out of San Francisco, California , by NewsRx editors, research stated, "Tumors consist of a heterogeneous ... 4 Traders, 5 days ago
In a Pivotal Study, Genentech's Investigational Immunotherapy Atezolizumab Shrank Tumors in People With a Specific Type of Bladder Cancer - Drugs.com, 1 week ago
Genentech (RHHBY)'s Breakthrough Atezolizumab Joins Club of Successful Anti-PD-L1 Drugs, Shrinks Tumors in Bladder Cancer 7/14/2015 - ClinicSpace, 1 week ago
Many companies have been caught off-guard by the extent to which generic competition has eaten away at their sales. Genentech says it managed to be caught by surprise, however, by a lack thereof; leading to a shortage of the injectable version of ...FiercePharma, 2 hours ago
Recent Findings from Genentech, Inc. Provides New Insights into Immunoglobulins (Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class...
Recent Findings from Genentech, Inc. Provides New Insights into Immunoglobulins (Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors) By a ...4 Traders, 5 days ago Reports from Genentech, Inc. Highlight Recent Findings in Macular Edema (Predictors of Functional and Anatomic Outcomes in Patients with Diabetic... 4 Traders, 1 week ago Immune Pharmaceuticals to present bertilimumab at The International Eosinophil Society workshop on Personalized Medicine Pharmacy Choice, 1 day ago Emerging Pharma Leaders: Arjun Handa, Claris Lifesciences PharmExec.com, 1 week ago
SOUTH SAN FRANCISCO, Calif. Dr. Ho most recently served as Vice President of Early Clinical Development at Genentech, where she headed the early clinical development for all indications outside of oncology. She brings more than a decade of ...Pettinga Financial Advisors, 6 days ago More People News for July 22 Dow Jones Financial Information Services, 6 days ago Denali Appoints As Chief Medical Officer And Head Of Development BioSpace, 6 days ago PRONAI THERAPEUTICS : Appoints Dr. Barbara Klencke as Chief Development Officer 4 Traders, 1 week ago
Source: AC Immune SA Lausanne, Switzerland, July 13th, 2015 AC Immune SA today announced that it had received a milestone from Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), in its collaboration agreement for anti-Tau ...Pharma Voice, 1 week ago AC Immune receives milestone payment for crenezumab moving into phase III clinical development in Alzheimer's disease PharmaVOICE, 4 days ago
Studies from Genentech, Inc. Have Provided New Information about Ovarian Cancer (Upregulation of Periostin and Reactive Stroma Is Associated with...
Studies from Genentech, Inc. Have Provided New Information about Ovarian Cancer (Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer) By a News ...4 Traders, 5 days ago
The Genentech vets behind South San Francisco-based Denali Therapeutics have recruited one of their former colleagues to join them as CMO and head of research. Carole Ho, former VP of early clinical development at Genentech, was tapped for the job.FierceBiotech, 5 days ago
Deadline: September 30, 2015 The ARVO Foundation for Eye Research , the philanthropic arm of the Association of Research in Vision and Ophthalmology , was established in 2001 to ensure stable support for innovative and novel vision research, ...Philanthropy News Digest, 1 week ago
Listed below are all new filings before PTAB of requests for inter partes review (IPR) and covered business methods review (CBM). Also listed are any newly-posted requests for ex parte reexamination at the USPTO. This listing is current as of 9:15 ...National Law Review, 1 hour ago
July 28, 2015 11:00 UTC Second-Quarter 2015 Reported Revenues (1) of $11.9 Billion Second-Quarter 2015 Adjusted Diluted EPS (2) of $0.56, Reported Diluted EPS (1) of $0.42 Raised Midpoints of 2015 Financial Guidance (3) Ranges for ...BioMedReports, 5 hours ago PFIZER : Reports second-quarter 2015 results 4 Traders, 5 hours ago AbbVie Reports Second-Quarter 2015 Financial Results CEOWorld Magazine, 4 days ago AbbVie (ABBV) Reports Second-Quarter 2015 Financial Results 7/24/2015 ClinicSpace, 3 days ago
on your WebpageAdd Widget >Get your members hooked!